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E-mail address: drc@le.ac.uk (D.R. Critchley).Mice homozygous for several Tln2 gene targeted alleles are viable and fertile. Here we show that
although the expression of talin2 protein is drastically reduced in muscle from these mice, other tissues
continue to express talin2 albeit at reduced levels. We therefore generated a Tln2 allele lacking the entire
coding sequence (Tln2cd). Tln2cd/cd mice were viable and fertile, and the genotypes of Tln2cd/+ intercrosses
were at the expected Mendelian ratio. Tln2cd/cd mice showed no major difference in body mass or the
weight of the major organs compared to wild-type, although they displayed a mildly dystrophic pheno-
type. Moreover, Tln2cd/cd mouse embryo ﬁbroblasts showed no obvious defects in cell adhesion, migra-
tion or proliferation. However, the number of Tln2cd/cd pups surviving to adulthood was variable
suggesting that such mice have an underlying defect.
 2012 Elsevier Inc. Open access under CC BY license.1. Introduction
The cytoskeletal protein talin plays a pivotal role in regulating
the activity of the integrin family of cell adhesion proteins and cou-
ples them to F-actin [1]. There are two talin genes that encode clo-
sely related (74% identity) proteins [2,3], but the relative roles of
talin1 and talin2 are not yet understood. Tln1 is a relatively simple
gene spanning approximately 30 kb, with 56 coding exons sepa-
rated by relatively small introns. It is ubiquitously expressed and
appears to give rise to a single major protein isoform. In contrast,
Tln2, the ancestral gene [4], spans >400 kb, and although the
genomic organization of the coding exons of the two genes is iden-
tical, the introns in Tln2 are much larger [2]. Moreover, Tln2 is a
more complex gene with several promoters and splice variants.
Talin2 is the predominant isoform in muscle and brain, but it is
not present in most cells of haemopoietic origin.
Knockout or knockdown of talin1 in cultured cells leads to
upregulation of talin2 which compensates for loss of talin1 [5,6].
However, in mice the functional relationship between the two pro-
teins is less clear. Mice homozygous for deletion of the ﬁrst four
Tln1 coding exons die at about 8.5 dpc due to gastrulation defects
[7], and hence, it had been assumed that talin2 was not expressed
at this stage in development. However, talin2 has recently been
shown to be present in embryonic epithelium at 7.5 dpc where itY license. 
As, focal adhesions.co-localises with talin1 and b1-integrin in cell/basement mem-
brane junctions [8]. Nevertheless, it fails to compensate for loss
of talin1 during the formation of the polarised elongated epithelial
layer of the epiblast. Subsequent developmental processes appear
to be less dependent on talin1, and conditional knockout of talin1
post 8.5dpc does not affect the development of most tissues/organs
of the embryo other than the blood vessels, which fail to form
properly due to defects in endothelial cell morphogenesis [9]. This
is readily explained since endothelial cells express only talin1. The
fact that deletion of talin1 does not affect development of other or-
gans suggests that talin2 may be the functionally more important
isoform in the majority of tissues.
To address the importance of talin2 during mouse development,
we have used several gene trap alleles as well as a conditional al-
lele in which the ﬁrst coding exon of Tln2 is ﬂanked by loxP sites. In
all cases, mice homozygous for these various Tln2 alleles were via-
ble and fertile arguing against a major role for talin2 in develop-
ment [2,10]. However, the lack of isoform-speciﬁc antibodies
made it impossible to establish whether such mice continue to ex-
press talin2 protein. Here we report the use of isoform-speciﬁc ta-
lin monoclonal antibodies [11] to show that talin2 is indeed
expressed in some tissues in these mice suggesting that this may
account for the lack of phenotype. We therefore generated a new
Tln2 allele containing loxP sites at the 50 and 30 end of the ﬁrst
and last coding exons allowing complete deletion (cd) of the Tln2
coding sequence. Remarkably, although the Tln2 gene is widely ex-
pressed in wild-type mice, animals unable to express any talin2
exhibited no apparent developmental phenotype, and adult
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mild form of muscular dystrophy similar to that previously
reported using the exon1 deleted Tln2 allele [12].Fig. 1. Talin2 protein is still expressed in current talin2 knockout mouse models.
Western blotting for talin2 using the talin2-speciﬁc 68E7 monoclonal antibody [11]
on brain and heart from wild-type (WT) male (M) and female (F) mice plus three
Tln2 transgenic mouse lines; KO (exon1 deletion) [12]; GT4 (gene trap insertion in
Tln2 coding sequence which generates a fusion protein containing the N-terminal
half of talin2 fused to b-galactosidase [13], and SGT (gene trap insertion in 50 UTR).2. Methods
2.1. Mouse strains
The following previously reported mouse strains were used
in this study; Tln2KO (Tln2tm1.1Crit) where Tln2 coding exon1 is
deleted [12]; Tln2sgt (Tln2Gt(S1-6D1)Sor) with a gene trap
insertion upstream of the ﬁrst coding exon [2,13]; Tln2gt4
(Tln2Gt(RRI434)Byg) with a gene trap insertion between coding
exons 28 and 29 [2,13]. Mice (Tln2cd/cd) homozygous for complete
deletion of the Tln2 coding sequence were generated in this study
as described in Fig. S1 and Supplementary Methods.2.2. Analysis of embryos, tissues and cells from Tln2cd/cd mice
Talin1 and talin2 in embryos and tissues fromgenotypedanimals
weredetectedbyWesternblottingusing the isoform-speciﬁcmouse
monoclonal antibodies 68E7 and 97H6 respectively [11] as de-
scribed in Supplementary Methods. Vinculin was detected using
the mouse monoclonal antibody F9 (1:400), and FAK using an in
house rabbit polyclonal antibody. Talin1 and talin2 in mouse em-
bryo ﬁbroblasts (MEFs) were visualised using the 68E7 and 97H6
antibodies as described by [11]. To determine rates of proliferation,
cells were seeded on 6-cm dishes (105 cells per dish) and counted
every two days using a hemocytometer. Cell cycle distribution was
determined on cells ﬁxed in 70% ethanol, washed in PBS, treated
with 0.5 mg/ml RNAseA (Sigma), stainedwith propidium iodide fol-
lowing the manufacturer’s protocol (e-Bioscience), and analysed
using FAC SCanto™ II and FACS Diva software (BDBiosciences). Akt
activation was assessed using conﬂuent monolayers of serum-
starved MEFs treated with 10% serum for 30 min. phospho-Akt
(Ser-473) was detected by Western blotting with an antibody from
Cell Signaling (Danvers, MA) diluted 1:1000. Bound primary anti-
bodywasdetectedwithhorseradishperoxidase-conjugated second-
ary antibodies (Sigma, 1:5000) and visualised using a SuperSignal
West Femto ECL kit (Thermo Scientiﬁc). Immunohistochemistry on
muscle was carried out as described previously [10,14].3. Results
We have previously described a conditional Tln2 allele (Tln2ko)
in which the ﬁrst coding exon is ﬂanked with loxP sites [12]. By
crossing mice carrying this allele to the Cre deleter mouse, we gen-
erated mice that were homozygous for loss of the ﬁrst Tln2 coding
exon (Tln2ko/ko). The mice were viable and fertile, and Western
blotting with a talin2 speciﬁc polyclonal antibody showed loss of
talin2 protein from skeletal muscle resulting in a mildly dystrophic
phenotype [12]. Here, we show that talin2 expression was also ab-
lated in heart, but substantial amounts of talin2 were still detect-
able in brain (Fig. 1), spleen and kidney (data not shown),
presumably due to alternative promoter usage or exon skipping.
We also analysed talin2 protein expression in two Tln2 genetrap
mouse lines that show no obvious phenotype. GT4 contains an
insertion in Tln2 coding sequence that creates a fusion protein con-
taining the N-terminal half of talin2 fused to b-galactosidase [13].
It is clearly expressed in brain and heart (Fig. 1) and kidney and
spleen (data not shown), but at reduced levels compared to full-
length talin2. SGT contains a gene trap insertion in the 50UTR [2],
and still expressed talin2 in heart (unlike the Tln2ko/ko line) albeitat reduced levels (Fig. 1), and also in brain (Fig. 1), kidney and
spleen (data not shown).
Since the lack of any developmental defects in these mice may
be due to the continued expression of talin2 in some tissues, we
decided to generate a truly null Tln2 allele (Tln2cd) by deleting
the entire coding sequence. The targeting strategy is outlined in
Fig. S1A. In brief, we took ES cells in which the ﬁrst Tln2 coding
exon was ﬂanked by LoxP sites (Tln2ﬂ allele; referred to as the 50
targeted allele in Fig. S1), and introduced an additional loxP site
in the 30UTR (exon 56) between the stop codon and the polyade-
nylation signal to generate a 50 and 30 targeted allele (Fig. S1A).
Southern blotting conﬁrmed that the 30 end of the Tln2 gene was
successfully targeted in ES clones 369, 374 and 397 (Fig. S1B). Each
of these three ES cell lines were then transiently transfected with a
Cre recombinase expression construct to delete any sequence
ﬂanked by loxP sites. The two possible outcomes are shown
Fig. S1A. Where the 50 and 30 targeting events are in cis, then both
the Tln2 coding sequence and the tyrosine kinase (TK) selection
cassette will be completely deleted which will not be the case if
the two targeting events are in trans. To identify the required ES
cell lines, transfectants were cultured in the presence of ganciclovir
and individual resistant sub-clones were screened by Southern
blotting (Fig. S1B) and PCR (not shown). 6 clones (369.3, 369.5,
369.4, 374.1, 374.2 and 397.3) were identiﬁed in which the entire
Tln2 coding region had been deleted.
Mice were generated from some of these ES cell clones, and
genotyped by PCR to conﬁrm that they possessed the deleted
Tln2cd allele (not shown). Mice homozygous for complete deletion
(Tln2cd/cd) appeared indistinguishable from their heterozygous and
wild-type littermates. Analysis of lysates from 12.5dpc embryos
conﬁrmed that Tln2cd/cd embryos had no detectable talin2 protein
while Tln2cd/+ embryos showed a reduction in talin2 compared to
wild-type (Fig. 2A).
Intercrossing Tln2+/cd mice produced the expected Mendelian
ratios ofmale and femalewild-type, homozygous and heterozygous
progeny (Fig. 2B). We also bred bothmale and female Tln2cd/cd mice
to wild type animals and these all produced litters of similar size
and numbers compared to Tln2+/cd mice. Thus, Tln2cd/cd mice are
viable and fertile. However, it was difﬁcult to maintain a breeding
colony of Tln2cd/cd for unexplained reasons indicating that the mice
have an underlying defect. We looked at the growth rates of
Tln2cd/cd compared to wild-type mice, and although the numbers
were small, therewas no clear difference in rate of weight gain after
birth (Fig. 2C). Additionally there were no signiﬁcant differences in
the proportional weights of any of the major organs in Tln2cd/cd
mice compared to wild-type, either for males or females (Fig. S2),
including the brain where talin2 is the predominant isoform [11].
The Tln2cd/cd mice did exhibit a mild form of muscular dystrophy
at 5 months as indicated by themarked increase in centrally located
nuclei (Fig. 3), a phenotype very similar to that of Tln2ko/ko mice
which are only missing coding exon1 [12].
AB
C
Fig. 2. Talin2 null (Tln2cd/cd) mice possess no overt phenotype. (A) Tln2cd/+ mice were intercrossed and 12.5 dpc embryos of the genotypes shown screened for talin1 and
talin2 byWestern blotting. Tln2cd/cd embryos contained no talin2 protein while levels of talin1 and focal adhesion kinase (FAK) were unchanged. (B) Tln2cd/+ intercrosses gave
rise to the three possible genotypes at the expected frequency for both sexes indicating that the loss of talin2 does not result in embryonic or neonatal lethality. (C) Weights of
male (left) and female (right) Tln2cd/cd and Tln2+/+ mice plotted against days (blue circle, WT mice; red square, Tln2cd/cd mice). The average weight for each group is displayed
as a black bar. Both male and female Tln2cd/cd mice tended to be smaller than their control littermates, but this was not statistically signiﬁcant.
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from 13.5dpc embryos (Fig. S3A) showed slightly reduced rates of
cell proliferation compared to wild-type (Fig. 4A), although there
were no obvious defects in cell cycle progression or any increase
in apoptosis as indicated by FACS analysis (Fig. 4B) or Western
blotting for PARP cleavage (data not shown). Tln2cd/cd MEFs
showed no obvious defects in cell spreading and assembled cell-
extracellular matrix junctions (focal adhesions; FAs) and associ-
ated actin stress ﬁbres despite the lack of talin2 protein (Fig. 4C).
They also assembled an extensive ﬁbronectin extracellular matrix
(Fig. 4D), although we have previously shown that knockdown of
talin2 in NIH 3T3 cells compromises matrix assembly [11]. Rates
of wound closure on laminin-coated or uncoated tissue culture
plastic were also unaffected by loss of talin2 (Fig. 4E and Fig. S3B).
Subsequent to generating the Tln2cd/cd allele, it became appar-
ent that we had also deleted the miR190 gene which is contained
within the Tln2 gene. miR190 has recently been shown to suppress
expression of Leucine Rich Repeat Protein Phosphatase PHLPP [15]
which in turn negatively regulates AKT signaling. Loss of miR190
would therefore be predicted to result in upregulation of PHLPP
and suppression of AKT signaling. However, AKT was activated to
a similar extent in both Tln2cd/cd and wild-type MEFs following
addition of serum to serum-starved cells (Fig. 4F).4. Discussion
Although mice homozygous for two Tln2 gene trap alleles [2,13]
or a Tln2ko allele [12] are viable and fertile, it is now apparent that
these mice still express talin2 protein in several tissues. Thus, the
lack of phenotype is difﬁcult to interpret, and we therefore gener-
ated mice in which the whole of the Tln2 coding sequence was de-
leted. Surprisingly, the Tln2cd/cd null mice were also viable and
fertile, and inter-crossing Tln2cd/+ mice gave rise to the expected
ratios of wild-type, hetero- and homozygous mice. Moreover, the
weight of Tln2cd/cd mice and their major organs was no different
from wild-type animals. Similarly, preliminary analysis of blood
and urine showed no obvious abnormalities.
Although Tln2 is reported to be the ancestral gene [4], the spe-
ciﬁc function of talin2 protein has not been established in any
organism. Talin2 is more widely expressed than originally inferred
from Northern blots [3], and it is the most abundant isoform in
brain and muscle [11]. In vitro, talin2 is upregulated during
myoblast fusion [16] suggesting an important role in muscle
development, and talin2 co-localises with the muscle-speciﬁc
b1D-integrin splice variant in myotendinous junctions [10,12].
Consistent with this observation, Tln2cd/cd mice develop a mild
form of muscular dystrophy characterised by disruption of the
Fig. 3. Tln2cd/cd mice develop myopathy by 5 months of age. H&E stained gastrocnemius muscle from (A) wild-type (WT) and (B) Tln2cd/cd mice. Arrows in (B) indicate
centrally nucleated ﬁbres (CNF). (C) Quantiﬁcation of CNF in gastrocnemius muscle from Tln2+/+ (WT) and Tln2cd/cd mice. Data represent the mean ± S.D.; ⁄⁄ indicates
statistically signiﬁcant differences (p = 0.004). (D–K) Immunostaining of WT and Tln2cd/cd gastrocnemius muscle for talin2 (Tal2), a7-integrin (a7), laminin (Lm) and vinculin
(Vn). Talin2 is expressed in the myotendinous junction of WT muscle but is absent from Tln2cd/cd muscle. a7-integrin, which is also expressed at the myotendinous junction
shows similar expression in both samples. Laminin (Lm) and vinculin (Vn) expression also remains unchanged in Tln2cd/cd muscle. Scale bars = 50 lm.
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in mice homozygous for deletion of the ﬁrst Tln2 coding exon [12].
Deletion of this exon results in a near complete ablation of talin2
expression in muscle, whereas in other tissues, talin2 continues
to be expressed. Biochemical studies show that the N-terminal
talin2 FERM domain binds b1D-integrin with higher afﬁnity than
talin1 [17], and the data reported here suggest that the tight bind-
ing of talin2 to b1D-integrin is important in stabilizing the myoten-
dinous junction against the force exerted on it during muscle
contraction. Talin1 on the other hand is predominantly localised
in costameres, although there is some in myotendinous junctions.
Consistent with this, muscle-speciﬁc knockout of talin1 gives rise
to a less severe myopathy than that caused by talin2 knockout
[10]. Interestingly, combined loss of talin1 and 2 frommuscle leads
to an embryonic lethal phenotype with defects in myoblast fusion
[12]. Thus, in skeletal muscle, talin1 and talin2 appear to have dis-
tinct but overlapping functions.
Studies on cells in culture clearly establish that talin2 can com-
pensate for loss of talin1, and talin2 can support cell spreading and
FA assembly in talin1 knockout or knockdown cells [5,6]. However,
as in muscle, the localization of the two proteins is subtly distinct
[11] and Fig. 4C – talin1 is localised in FAs, while talin2 extends be-
yond FAs along actin stress ﬁbres into ﬁbrillar adhesions, struc-
tures involved in ﬁbronectin matrix assembly. However, Tln2cd/cd
null cells showed no changes in the localization of talin1 nor any
differences in cell spreading, FA formation, ﬁbronectin matrix
assembly or rates of wound closure. Given these ﬁndings, it is
remarkable that germ line loss of talin1 results in embryonic
lethality at gastrulation [7] despite the fact that talin1 and talin2
co-localise with b1-integrins in the basal aspect of the embryonic
epithelium where cells contact the basement membrane [8]. In vi-
tro studies show that although talin2 localisation in the embryonicepithelium is not affected by loss of talin1, both recruitment of
paxillin to cell-matrix junctions and FAK signaling are both com-
promised, and the steady state level of b1-integrin was markedly
reduced due to proteasomal-mediated degradation. Thus in the
embryonic epithelium, talin1 rather than talin2 is required for epi-
thelial cell polarisation and extension, the stabilization of b1-inte-
grins and for integrin signaling.
Talin2 is not expressed in cells of hematopoetic origin [18]
including platelets [19], and knockout of talin1 does not lead to
upregulation of talin2 in these cells. In contrast, knockout of Tln1
in ﬁbroblasts leads to the rapid upregulation of talin2 [6]. The ma-
jor Tln2 promoter is embedded in a CpG island and it is presumably
silenced in hematopoetic cells by methylation [2]. Little is known
about the transcription factors that regulate talin2 expression [2]
although Tln2 transcription is stimulated by the transcription fac-
tor YY1, an effect silenced by ERK-mediated YY1 phosphorylation
[20] (Fig. S4). Talin2 expression is negatively regulated at the
translational level by miR-132 [21] and also by the fragile X related
protein FXR1 which binds to the 30 end of the Tln2 mRNA and re-
presses translation [22] (Fig. S4). Expression of the desmosomal
protein desmoplakin is also regulated in the same way. Interest-
ingly, knockout of FXR1 in heart leads to the upregulation of talin2
and desmoplakin proteins which compromises the integrity of
costameres (where talin1 is localised) and desmosomes. Clearly,
tight regulation of talin2 levels is essential to normal cardiac func-
tion, although the data reported here suggest that basal cardiac
function is normal in Tln2cd/cd mice.
A recently noted feature of the Tln2 gene is that it encodes the
micro-RNA miR-190 which is contained within intron 51 towards
the 30-end of the gene [2]. Recent studies show that expression
of both Tln2 and miR-190 are markedly increased by trivalent ar-
senic As3+ [15]. miR-190 down-regulates expression of the PH do-
Fig. 4. Tln2cd/cd mouse embryo ﬁbroblasts (MEFs) show no proliferation, adhesion or migration defects. (A) Tln2cd/cd MEFs grew slightly slower than wild-type (WT) cells;
(mean values ± S.D. (B) Cell cycle distribution of Tln2cd/cd andWTMEFs was indistinguishable. (C) Tln2cd/cd and Tln2 WTMEFs plated on plastic and stained for either talin1 or
talin2 (green) and actin (red). Scale bar 10 lm. Talin2 null MEFs were able to spread and assemble talin1-containing focal adhesions and actin stress ﬁbres, and also (D)
assembled an extensive ﬁbronectin matrix. (E) Tln2cd/cd andWT MEFs showed similar rates of wound closure on either laminin or plastic. Line indicates range. (F) Akt activity
in Tln2cd/cd and WT MEFs was determined by Western blotting using a phospho473-AKT antibody. Serum-starved cells were stimulated with serum 30 min prior to analysis.
(For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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which in turn negatively regulates the activity of Akt (Fig. S4). Asa result, increased miR-190 expression enhances Akt signaling,
and miR-190 over-expression stimulates cell proliferation and
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gene in the Tln2cd/cd mice would be predicted to increase PHLPP
phosphatase activity and thereby decrease Akt signaling. Down-
regulation of Akt has the potential to affect numerous pathways,
and could lead to p21-induced cell cycle arrest, increased
Bax-mediated apoptosis and reduced mTOR-mediated transla-
tional initiation. miR-190 has also been implicated in the negative
regulation of TGF-b signaling [23]. However, Tln2cd/cd MEFs
showed normal cell cycle progression although their doubling time
was marginally slower than wild-type MEFs. Moreover, there was
no evidence of increased apoptosis, and serum-stimulated AKT lev-
els were comparable in the Tln2cd/cd and wild-type MEFs. Overall, it
is clear from these studies that neither talin2 nor miR-190 are
essential for normal mouse development or the viability and fertil-
ity of adult mice, despite the fact that talin2 expression is tightly
regulated at both transcriptional and translational levels. However,
maintaining a breeding colony of Tln2cd/cd mice is challenging for
unexplained reasons, while Tln2ko/ko mice in which the ﬁrst codon
exon has been deleted [12], and continue to express reduced levels
of talin2 in non-muscle tissues, show no such problems. Complete
loss of talin2, miR-190 or both may contribute to this phenotype.
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